Michael Osswald
Hematology & Oncology · Lackland A F B, TXNPI 1467565911
Payments from drug & device makers
Across 65 payments — averaging $7796.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acerta Pharma LLC$252K
- Astrazeneca UK Limited$89K
- Bristol Myers Squibb$79K
- E.r. Squibb & Sons, L.L.C.$45K
- Eli Lilly$22K
- Genmab A/s$15K
- plus $5K from 2 others
Across 2 payments — averaging $825.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$2K
What the payments were for
- Food & beverage$121100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acerta Pharma LLC | 23 | $252,194 |
| Astrazeneca UK Limited | 7 | $88,734 |
| Bristol Myers Squibb | 15 | $79,146 |
| E.r. Squibb & Sons, L.L.C. | 4 | $44,594 |
| Eli Lilly | 5 | $21,743 |
| Genmab A/s | 7 | $14,915 |
| AstraZeneca | 3 | $5,344 |
| Tempus AI, Inc | 1 | $121 |
How this compares
$506,792 in reported general payments places this provider in the 80th percentile of 838 hematology & oncology providers in Texas.
Other hematology & oncology in Lackland A F B
- Elias JabbourHouston$264.1M
- Luhua WangHouston$79.6M
- Courtney DinardoHouston$74M
- Jorge Cortes-FrancoHouston$59.4M
- William WierdaHouston$58.7M
- Koji SasakiHouston$39.2M
- Kyriakos PapadopoulosSan Antonio$18.5M
- Loretta NastoupilHouston$18.3M
- Christopher FlowersHouston$17.2M
- Drew RascoSan Antonio$14.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.